Sickle Cell Disease: Discussions on the Challenges and Best Practices to Address the Gaps in Care

This activity was originally broadcast live as a satellite symposium held in conjunction with the 2022 AMCP Annual Meeting.

Program Description

Patients with sickle cell disease (SCD) are at risk for developing life-threatening complications and often require hospitalizations. A greater understanding of the pathophysiology of SCD has led to new treatment and management options and has increased the median age of patients with SCD. Managed care professionals need to recognize the potential challenges with the transition of patients with SCD as adults, namely the gaps in access to insurance and medical care. Additionally, patients with SCD who seek symptomatic relief of vaso-occlusive crises with pain management often face stigma, indicating an important opportunity for managed care professionals to evaluate existing protocols and opportunities to ensure equal access to care. This activity will feature a panel of experts who will share perspectives on current treatment challenges and disparities of care affecting people with SCD as well as discuss solutions managed care pharmacists can incorporate into the management plans of patients with SCD.

Target Audience: Managed care pharmacists and specialty pharmacists

Type of Activity: Application
Release date: April 22, 2022
Expiration date: April 22, 2023

Time to complete activity: 1.5 hours
Fee: Free

Educational Objectives

At the completion of this activity, participants will be able to:

• Explore the specific medical needs of patients with sickle cell disease (SCD), including its impact throughout the life cycle.
• Compare the clinical data for available and emerging pharmacotherapy for evidence-based management of SCD.
• Discuss the social determinants of health that are common to patients with SCD and their impact on access to care.
• Examine the practices and strategies of other managed care organizations in the management of patients with SCD as measured by their health outcomes and the optimization of healthcare resources

Pharmacy Times Continuing Education^™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.5 contact hours (0.15 CEU) under the ACPE universal activity number 0290-0000-22-198-H01-P. The activity is available for CE credit through April 22, 2023.

Instructions for Completing the Activity and Receiving CPE Credit

To receive CPE credit, participants must complete the pretest, view the activity in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.

Disclosures

Lindsey Dayer, PharmD, has no relevant financial relationships with commercial interests to disclose.

Andrew Campbell, MD, has the following relevant financial relationships with commercial interests to disclose:

Grant/research support: Global Blood Therapeutics, Novartis, Forma Therapeutics, Agios Pharmaceuticals

Consultant: Global Blood Therapeutics, Novartis, Forma Therapeutics, Agios Pharmaceuticals

Lametra Scott, PharmD, has the following relevant financial relationship with a commercial interest to disclose:

Grant reviewer for Access to Excellent Care for Sickle Cell Patients (ACCEL), Global Blood Therapeutics.

Pharmacy Times Continuing Education^™ Planning Staff— Jim Palatine, RPh, MBA; Maryjo Dixon, RPh, MBA; Karleen Melody, PharmD; Crissy Wilson; Susan Pordon; Brianna Winters; and Chloe Taccetta have no financial relationships with commercial interests to disclose.

Anonymous peer reviewers have been used as part of content validation and conflict resolution. The peer reviewers have no relevant financial relationships with commercial interests to disclose.

Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.

For questions about this internet CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms